BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28914715)

  • 1. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
    J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
    Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
    Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
    North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
    Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features.
    Bishop JA; Andreasen S; Hang JF; Bullock MJ; Chen TY; Franchi A; Garcia JJ; Gnepp DR; Gomez-Fernandez CR; Ihrler S; Kuo YJ; Lewis JS; Magliocca KR; Pambuccian S; Sandison A; Uro-Coste E; Stelow E; Kiss K; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1690-1701. PubMed ID: 28877065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
    Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
    Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
    Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.
    Papadaki H; Finkelstein SD; Kounelis S; Bakker A; Swalsky PA; Kapadia SB
    Hum Pathol; 1996 Jun; 27(6):567-72. PubMed ID: 8666366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
    Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
    Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.
    Hanna GJ; Grover P; Elliott A; McGrath J; Xiu J; Sukari A; Johnson JM; Wise-Draper T
    Clin Cancer Res; 2024 May; 30(10):2225-2232. PubMed ID: 38416410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.
    Ling S; Rettig EM; Tan M; Chang X; Wang Z; Brait M; Bishop JA; Fertig EJ; Considine M; Wick MJ; Ha PK
    Int J Oncol; 2016 Jul; 49(1):225-34. PubMed ID: 27212063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-alpha in adenoid cystic carcinoma of the salivary gland.
    Chiang CP; Chen CH; Liu BY; Sun A; Leu JS; Wang JT
    J Formos Med Assoc; 2001 Jul; 100(7):471-7. PubMed ID: 11579613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.
    Massé J; Truntzer C; Boidot R; Khalifa E; Pérot G; Velasco V; Mayeur L; Billerey-Larmonier C; Blanchard L; Charitansky H; Soubeyran I; Iggo R; Arnould L; MacGrogan G
    Mod Pathol; 2020 Jun; 33(6):1041-1055. PubMed ID: 31857685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.
    Ferrarotto R; Mitani Y; McGrail DJ; Li K; Karpinets TV; Bell D; Frank SJ; Song X; Kupferman ME; Liu B; Lee JJ; Glisson BS; Zhang J; Aster JC; Lin SY; Futreal PA; Heymach JV; El-Naggar AK
    Clin Cancer Res; 2021 Feb; 27(3):852-864. PubMed ID: 33172898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of the distribution of lysozyme, lactoferrin, alpha 1-antitrypsin and alpha 1-antichymotrypsin in salivary adenoid cystic carcinoma.
    Chomette G; Auriol M; Vaillant JM; Kasai T; Niwa M; Mori M
    Pathol Res Pract; 1991 Dec; 187(8):1001-8. PubMed ID: 1665225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
    Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas.
    Cavalcante RB; Nonaka CFW; Santos HBP; Rabenhorst SHB; Pereira Pinto L; de Souza LB
    Virchows Arch; 2018 Jun; 472(6):999-1005. PubMed ID: 29577164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.